Browse our news
Read the latest news on university research, initiatives and successes.
-
NEWS
Fighting aggressive blood cancer ages and exhausts immune cells, study shows
28 November 2022The most aggressive form of blood cancer ages immune cells and drives them to exhaustion, to the point where their ability to fight the disease is significantly impaired, a new study suggests.
ntu.ac.uk/about-us/news/news-articles/2022/11/fighting-aggressive-blood-cancer-ages-and-exhausts-immune-cells,-study-shows
-
NEWS
UK Aid funding for Nottingham research to develop Zika virus vaccine
21 February 2022Scientists in Nottingham have been awarded £462,462 for the development of a vaccine for the Zika virus from £10m of UK Aid funding for research into vaccines to protect the world from deadly diseases.
ntu.ac.uk/about-us/news/news-articles/2022/02/uk-aid-funding-for-nottingham-research-to-develop-zika-virus-vaccine
-
NEWS
Exercise prompts cells to react in a way that could protect against bone cancer and other bone-related illnesses, research suggests
5 July 2021A single bout of exercise triggers processes in bone cells which could help to protect against the spreading of cancer to the bones, a new study suggests.
ntu.ac.uk/about-us/news/news-articles/2021/06/exercise-prompts-cells-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests
-
NEWS
Funding will allow clinical trials for COVID-19 vaccine to begin in Nottingham
27 August 2020Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19.
ntu.ac.uk/about-us/news/news-articles/2020/08/funding-will-allow-clinical-trials-for-covid-19-vaccine-to-begin-in-nottingham
-
NEWS
Gene could guide better treatment of most common breast cancer
5 August 2020Scientists have identified a gene which if present in certain breast cancer patients indicates how they will respond to specific therapies.
ntu.ac.uk/about-us/news/news-articles/2020/08/gene-could-guide-better-treatment-of-most-common-breast-cancer
-
NEWS
New blood test can confirm prostate cancer – and what stage it is at
28 July 2020A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.
ntu.ac.uk/about-us/news/news-articles/2020/07/new-blood-test-can-confirm-prostate-cancer-and-what-stage-it-is-at
-
NEWS
Study paves way for faster, more accurate therapies for hard-to-treat leukaemia patients
4 June 2020A new study will enable clinicians to identify patients with aggressive leukaemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.
ntu.ac.uk/about-us/news/news-articles/2020/06/study-paves-way-for-faster,-more-accurate-therapies-for-hard-to-treat-leukaemia-patients
-
NEWS
Universities in Nottingham to play a key role in the development of a potential DNA vaccine against COVID-19
24 April 2020Scientists at the University of Nottingham and Nottingham Trent University will contribute essential virology expertise to help develop a safe and effective vaccine to prevent COVID-19.
ntu.ac.uk/about-us/news/news-articles/2020/04/universities-in-nottingham-to-play-a-key-role-in-the-development-of-a-potential-dna-vaccine-against-covid-19
-
NEWS
Scientists developing new vaccine approach for most aggressive brain cancer
25 February 2020Scientists are developing a combined vaccine to fight the most deadly form of brain cancer.
ntu.ac.uk/about-us/news/news-articles/2020/02/scientists-developing-new-vaccine-approach-for-most-aggressive-brain-cancer
-
Scientists have discovered a gene ‘signature’, the presence of which can “significantly improve” the accuracy of assessing how badly a patient may be affected by a form of leukaemia.
ntu.ac.uk/about-us/news/news-articles/2019/07/gene-signature-reveals-the-severity-of-disease-in-patients-with-blood-cancer